Sarissa Capital Management as of Dec. 31, 2019
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 13 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medicines Company | 29.6 | $357M | 4.2M | 84.94 | |
| Biogen Idec (BIIB) | 15.8 | $191M | 643k | 296.73 | |
| Ironwood Pharmaceuticals (IRWD) | 11.4 | $137M | 10M | 13.31 | |
| Intercept Pharmaceuticals In | 8.8 | $107M | 860k | 123.92 | |
| Allergan | 7.4 | $89M | 468k | 191.17 | |
| Innoviva (INVA) | 7.3 | $88M | 6.2M | 14.16 | |
| Alkermes (ALKS) | 6.4 | $78M | 3.8M | 20.40 | |
| Medicines Company convertible security | 5.7 | $68M | 20M | 3.42 | |
| Jazz Pharmaceuticals (JAZZ) | 5.5 | $66M | 444k | 149.28 | |
| Mersana Therapeutics (MRSN) | 1.8 | $22M | 3.8M | 5.73 | |
| Regulus Therapeutics | 0.1 | $1.6M | 1.9M | 0.89 | |
| Abbvie (ABBV) | 0.0 | $88k | 1.0k | 88.00 | |
| Mirati Therapeutics | 0.0 | $128k | 1.0k | 128.00 |
